Systems Modeling of Molecular Mechanisms Controlling Cytokine-driven CD4+ T Cell Differentiation and Phenotype Plasticity

Differentiation of CD4+ T cells into effector or regulatory phenotypes is tightly controlled by the cytokine milieu, complex intracellular signaling networks and numerous transcriptional regulators. We combined experimental approaches and computational modeling to investigate the mechanisms controlling differentiation and plasticity of CD4+ T cells in the gut of mice. Our computational model encompasses the major intracellular pathways involved in CD4+ T cell differentiation into T helper 1 (Th1), Th2, Th17 and induced regulatory T cells (iTreg). Our modeling efforts predicted a critical role for peroxisome proliferator-activated receptor gamma (PPARγ) in modulating plasticity between Th17 and iTreg cells. PPARγ regulates differentiation, activation and cytokine production, thereby controlling the induction of effector and regulatory responses, and is a promising therapeutic target for dysregulated immune responses and inflammation. Our modeling efforts predict that following PPARγ activation, Th17 cells undergo phenotype switch and become iTreg cells. This prediction was validated by results of adoptive transfer studies showing an increase of colonic iTreg and a decrease of Th17 cells in the gut mucosa of mice with colitis following pharmacological activation of PPARγ. Deletion of PPARγ in CD4+ T cells impaired mucosal iTreg and enhanced colitogenic Th17 responses in mice with CD4+ T cell-induced colitis. Thus, for the first time we provide novel molecular evidence in vivo demonstrating that PPARγ in addition to regulating CD4+ T cell differentiation also plays a major role controlling Th17 and iTreg plasticity in the gut mucosa.

[1]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[2]  Hua Huang,et al.  IFN-γ Suppresses STAT6 Phosphorylation by Inhibiting Its Recruitment to the IL-4 Receptor1 , 2005, The Journal of Immunology.

[3]  Hergen Spits,et al.  IL‐22‐producing CD4+ T cells: Middle‐men between the immune system and its environment , 2010, European journal of immunology.

[4]  Asher Zilberstein,et al.  Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN‐γ or IL‐4: Characterization of Th cells isolated by FACS based on IFN‐γ and IL‐4 secretion , 2005 .

[5]  T. Mcclanahan,et al.  TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.

[6]  M. Roncarolo,et al.  T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. , 2000, The Journal of allergy and clinical immunology.

[7]  Dušica Vidović,et al.  Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand , 2011, Nature.

[8]  Raquel Hontecillas,et al.  Modeling the Role of Peroxisome Proliferator-Activated Receptor γ and MicroRNA-146 in Mucosal Immune Responses to Clostridium difficile , 2012, PloS one.

[9]  Jonathan R. Karr,et al.  A Whole-Cell Computational Model Predicts Phenotype from Genotype , 2012, Cell.

[10]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[11]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[12]  Irma Joosten,et al.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. , 2008, Blood.

[13]  Raquel Hontecillas,et al.  The Role of Peroxisome Proliferator-Activated Receptor γ in Immune Responses to Enteroaggregative Escherichia coli Infection , 2013, PloS one.

[14]  H. Kacser,et al.  The control of flux. , 1995, Biochemical Society transactions.

[15]  Alan S. Perelson,et al.  Dynamics of CD4+ T Cell Responses against Listeria monocytogenes , 2012, The Journal of Immunology.

[16]  Andreas Radbruch,et al.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. , 2010, Immunity.

[17]  Sefik Alkan,et al.  Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion. , 2005, European journal of immunology.

[18]  Chen Dong,et al.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. , 2008, Immunity.

[19]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[20]  David J. Klinke,et al.  Quantifying Crosstalk Among Interferon-γ, Interleukin-12, and Tumor Necrosis Factor Signaling Pathways Within a TH1 Cell Model , 2012, Science Signaling.

[21]  John J. Tyson,et al.  A Mathematical Model for the Reciprocal Differentiation of T Helper 17 Cells and Induced Regulatory T Cells , 2011, PLoS Comput. Biol..

[22]  Michael Famulok,et al.  The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of experimental medicine.

[23]  D. Littman,et al.  Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. , 2011, Gastroenterology.

[24]  Hongmei Li,et al.  IL-9: Basic Biology, Signaling Pathways in CD4+ T Cells and Implications for Autoimmunity , 2010, Journal of Neuroimmune Pharmacology.

[25]  Jian Zhang,et al.  Cutting Edge: CTLA-4–B7 Interaction Suppresses Th17 Cell Differentiation , 2010, The Journal of Immunology.

[26]  Ke Wu,et al.  IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer , 2011, The Journal of Immunology.

[27]  Peter J. Morrison,et al.  Interleukin‐23 and T helper 17‐type responses in intestinal inflammation: from cytokines to T‐cell plasticity , 2011, Immunology.

[28]  Hua Huang,et al.  IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. , 2005, Journal of immunology.

[29]  Erin Nevius,et al.  Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Immunoregulation: Enhancement of Regulatory T Cells through PPARγ-Dependent and -Independent Mechanisms , 2007, The Journal of Immunology.

[30]  Erin Nevius,et al.  Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. , 2007, Journal of immunology.

[31]  Reinhart Heinrich,et al.  A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. , 1974, European journal of biochemistry.

[32]  Stuart Adams,et al.  Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment , 2010, Proceedings of the National Academy of Sciences.

[33]  Luis Mendoza,et al.  A network model for the control of the differentiation process in Th cells. , 2006, Bio Systems.

[34]  T. Hla,et al.  The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses1 , 2000, The Journal of Immunology.

[35]  Hitoshi Hasegawa,et al.  Regulatory T Cells + Functional Foxp3 T Cells into - CD25+ Convert Human CD4 b Agonists Together with TGF- g and a Peroxisome Proliferator-Activated Receptor , 2010 .

[36]  M. Manns,et al.  Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. , 2011, Blood.

[37]  M. Maurin,et al.  REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .

[38]  Wei Shi,et al.  All-Trans Retinoic Acid Promotes TGF-β-Induced Tregs via Histone Modification but Not DNA Demethylation on Foxp3 Gene Locus , 2011, PloS one.

[39]  Michael W. Sneddon,et al.  Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response , 2010, Molecular systems biology.

[40]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[41]  Manuel Rubio,et al.  CD28 Co-Stimulation Down Regulates Th17 Development , 2009, PloS one.

[42]  D. Littman,et al.  The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.

[43]  Andreas Radbruch,et al.  Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. , 2009, Immunity.

[44]  Dan R. Littman,et al.  Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity , 2011, Nature.

[45]  Mudita Singhal,et al.  COPASI - a COmplex PAthway SImulator , 2006, Bioinform..

[46]  Raquel Hontecillas,et al.  Peroxisome Proliferator-Activated Receptor γ Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis , 2007, The Journal of Immunology.

[47]  Rodrigo Liberal,et al.  Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. , 2012, Gastroenterology.

[48]  Jian Ye,et al.  Human tumor‐infiltrating Th17 cells have the capacity to differentiate into IFN‐γ+ and FOXP3+ T cells with potent suppressive function , 2011, European journal of immunology.

[49]  Ana Suárez,et al.  Immune Response to Bifidobacterium bifidum Strains Support Treg/Th17 Plasticity , 2011, PloS one.

[50]  Xiaoxiao Wan,et al.  FoxP3+RORγt+ T Helper Intermediates Display Suppressive Function against Autoimmune Diabetes , 2010, The Journal of Immunology.